Into the Eye of the Cytokine Storm
Open accessAbstract
SUMMARY: The cytokine storm has captured the attention of the public and the scientific community alike, and while the general notion of an excessive or uncontrolled release of proinflammatory cytokines is well known, the concept of a cytokine storm and the biological consequences of cytokine overproduction are not clearly defined. Cytokine storms are associated with a wide variety of infectious and noninfectious diseases. The term was popularized largely in the context of avian H5N1 influenza virus infection, bringing the term into popular media. In this review, we focus on the cytokine storm in the context of virus infection, and we highlight how high-throughput genomic methods are revealing the importance of the kinetics of cytokine gene expression and the remarkable degree of redundancy and overlap in cytokine signaling. We also address evidence for and against the role of the cytokine storm in the pathology of clinical and infectious disease and discuss why it has been so difficult to use knowledge of the cytokine storm and immunomodulatory therapies to improve the clinical outcomes for patients with severe acute infections.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that “cytokine storm” remains poorly defined despite its broad use, and that severe infections with respiratory viruses such as influenza, SARS-CoV, and dengue can drive overlapping, redundant proinflammatory cytokine networks that contribute to immunopathology. It highlights genomic evidence for cytokine/chemokine kinetics and host genetic variation, but concludes that immunomodulatory therapies have largely failed to improve outcomes in acute severe infections.
Key findings
- The term “cytokine storm” lacks a precise definition; its first use appears in a 1993 graft-versus-host disease article, infectious-disease use began in early 2000, and it was first applied to avian H5N1 influenza in 2005. A Google search at the time yielded 323,000 hits, over 170,000 within the past year.
- In severe infection, plasma cytokines follow a sequence: TNF and IL-1β plus chemokines IL-8 and MCP-1 appear early (minutes to hours), IL-6 rises more sustainedly, and IL-10 appears later as a counter-anti-inflammatory response; persistent downregulation of monocyte HLA-DR 3 to 4 days after severe sepsis and cytokine storm is associated with high mortality.
- Genomic studies show early and sustained innate immune gene activation: a Vietnamese H5N1 case study compared 18 H5N1-infected people with 8 seasonal H1N1-infected people and found elevated MCP-1/CCL2, IP-10/CXCL10, MIG/CXCL9, and IL-8 in those progressing to severe lung injury; macaque H5N1 lung microarray analysis identified 45 significantly differentially expressed cytokine and chemokine genes.
- Host genetics shape susceptibility: a hyperfunctioning TLR1 variant was linked to increased organ dysfunction and morbidity from Gram-positive bacteremia; TLR4 Asp299Gly occurred at high frequency in Ghanaian children with severe malaria; CISH polymorphisms were associated with bacteremia, tuberculosis, and severe malaria across several populations; and IFN-λ variants were associated with HCV clearance/treatment response.
- Therapeutic attempts targeting the host response have mostly failed: corticosteroids, aspirin, monoclonal antibodies, anti-cytokine/anti-chemokine agents, plasma exchange, and statins have not been proven effective, and some worsened outcomes. In mice, S1P1-selective agonists protected against lethal pandemic H1N1 without affecting viral replication; gemfibrozil improved survival in H2N2-infected mice; and zanamivir plus celecoxib/mesalazine increased survival in highly pathogenic H5N1-infected mice.
Methods
- Design: narrative review of cytokine storm in infection, with emphasis on respiratory viruses (influenza, SARS-CoV, dengue) and on high-throughput genomic approaches.
- Data/sample: no primary dataset or new sample; the paper synthesizes published human clinical studies, animal models (mice, macaques, ferrets, pigs, rabbits), in vitro cell studies, and clinical trial reports.
- Main analysis: integrates cytokine biology, pathology, host genetics, functional genomics/microarray findings, knockout and transgenic mouse studies, and immunomodulatory drug studies to describe mechanisms and therapeutic challenges.
Limitations
- The paper states that an actual definition of cytokine storm is lacking, that molecular events precipitating it are poorly understood, and that its contribution to pathogenesis and optimal therapeutic strategies remain unclear.
- The paper states that most studies rely on intermittent sampling from one compartment, typically peripheral blood, and measure only a few cytokines/chemokines, failing to interrogate the whole immune cascade in tissues; it also notes no agreement on what should be measured or how NGS data should be analyzed, and that interdependent systems are often studied in silos.
- Evident from the text: this is a narrative review without a systematic search or meta-analysis, it reports no new primary data, and several key mechanistic conclusions derive from animal models that may not fully mimic human disease—the paper itself notes, for example, that no animal models mimic severe dengue in humans.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 97 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Endogenous products such as oxidized phospholipids and matrix breakdown products also drive inflammation through TLR4 and probably other TLRs, providing a mechanism for perpetuating inflammation when microbial products are being cleared from the lungs.
“endogenous products such as oxidized phospholipids and matrix breakdown products also drive inflammation through TLR4 and probably other TLRs, providing a mechanism for perpetuating inflammation when microbial products are being cleared from the lungs (68,72).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
IL-1β is a key cytokine driving proinflammatory activity in bronchoalveolar lavage fluid of patients with lung injury.
“IL-1 is a key cytokine driving proinflammatory activity in bronchoalveolar lavage fluid of patients with lung injury (118).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
- Interpretationcitation
In severe infections affecting the deep tissues of the respiratory tract, it is probable that the immunological cascade that takes place directly in the deep tissues is crucial to immunopathology rather than what can be measured as a 'spillover' in the peripheral blood.
“For instance, in severe infections affecting the deep tissues of the respiratory tract (as has been described in avian influenza or severe primary influenza virus infections), it is probable that it is the immunological cascade that takes place directly in the deep tissues that is crucial to immunopathology rather than what can be measured as a “spillover” in the peripheral blood (28,82,128).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
The anti-inflammatory cytokine IL-10 appears somewhat later, as the body attempts to control the acute systemic inflammatory response.
“The anti-inflammatory cytokine IL-10 appears somewhat later, as the body attempts to control the acute systemic inflammatory response.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
In the lungs, the location of the initial infection does not seem to be a determinant of the severity of local and systemic cytokine storms.
“Interestingly, while the peripheral blood may not provide an accurate picture of the cytokine profiles in a tissue, in the lungs, the location of the initial infection does not seem to be a determinant of the severity of local and systemic cytokine storms.”
Quote in the paperSubstantial claim
- Premisecitation
An experimental study of rabbits with severe Pseudomonas pneumonia and systemic sepsis provided definitive evidence that TNF instilled into the lungs could pass into the systemic circulation, providing direct communication between the lungs and the bloodstream.
“An experimental study of rabbits with severe Pseudomonas pneumonia and systemic sepsis provided definitive evidence that TNF instilled into the lungs could pass into the systemic circulation, providing direct communication between the lungs and the bloodstream (80).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] source
Not checked in the free run.
- Premisecitation
Systemic production of IL-10 following the onset of a cytokine storm is a marker of a counter-anti-inflammatory response that has been termed 'immunoparalysis,' in that it is associated with downregulation of neutrophil and monocyte function in the systemic circulation.
“Systemic production of IL-10 following the onset of a cytokine storm is a marker of a counter-anti-inflammatory response that has been termed “immunoparalysis,” in that it is associated with downregulation of neutrophil and monocyte function in the systemic circulation (32,42,49).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
The intensity of the inflammatory response in the lungs reflects a balance between proinflammatory cytokines and their cognate soluble receptors or inhibitors, which inhibit the activity of these inflammatory cytokines in the aqueous phase of alveolar fluid.
“The intensity of the inflammatory response in the lungs reflects a balance between proinflammatory cytokines (e.g., TNF and IL-1) and their cognate soluble receptors or inhibitors (TNFR1, TNFR2, and IL-1RA), which inhibit the activity of these inflammatory cytokines in the aqueous phase of alveolar fluid (113).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] source
Not checked in the free run.
- Premisecitation
A recent GWAS identified multiple polymorphisms in CISH that were associated with increased susceptibility to bacteremia, tuberculosis, and severe malaria in persons in Gambia, Hong Kong, Kenya, Malawi, and Vietnam.
“A recent GWAS identified multiple polymorphisms in cytokine-inducible SRC homology 2 (SH2) domain protein (CISH), a SOCS family member that controls IL-2 signaling, that were associated with increased susceptibility to bacteremia, tuberculosis, and severe malaria in persons in Gambia, Hong Kong, Kenya, Malawi, and Vietnam (77).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
- Interpretationreasoning
Pigs appear to mount a protective proinflammatory response without tipping the scale to promote an adverse cytokine storm.
“It appears that pigs mount a protective proinflammatory response without tipping the scale to promote an adverse cytokine storm.”
Quote in the paperSubstantial claim - Premisecitation
In a large population of septic patients, those with a single nucleotide polymorphism (SNP) marking a hyperfunctioning variant of TLR1 had increased organ dysfunction and morbidity from Gram-positive bacteremia.
“In a large population of septic patients, those with a single nucleotide polymorphism (SNP) marking a hyperfunctioning variant of TLR1 had increased organ dysfunction and morbidity from Gram-positive bacteremia (150).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150] source
Not checked in the free run.
- Premisecitation
Microarray analysis of lung tissue from macaques infected with H5N1 virus revealed prolonged expression of CCL2, CXCL10, and CXCL9 genes among a gene set of 45 significantly differentially expressed cytokine and chemokine genes.
“Microarray analysis of lung tissue from macaques infected with H5N1 virus revealed prolonged expression of CCL2, CXCL10, and CXCL9 genes among a gene set of 45 significantly differentially expressed cytokine and chemokine genes (7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] source
Not checked in the free run.
- Premisecitation
In a macaque infection model, clinically distinct Mexican isolates of SOIV showed an increase in IL-6, TNF, and IL-1beta gene expression in the lungs and pronounced levels of IL-6 and MCP-1 in the plasma.
“In a macaque infection model, clinically distinct Mexican isolates of SOIV showed an increase in IL-6, TNF, and IL-1 gene expression in the lungs and pronounced levels of IL-6 and MCP-1 in the plasma (123).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [123] source
Not checked in the free run.
- Premisenone given
Many of the proinflammatory cytokines contributing to the cytokine storm were observed to play a protective role against 2009 H1N1 pandemic influenza virus infection.
“Many of the proinflammatory cytokines contributing to the cytokine storm were observed to play a protective role against 2009 H1N1 pandemic influenza virus infection.”
Quote in the paperNot a substantial claim - Premiseown data
Among the inflammatory response genes differentially regulated by 1918 and H5N1 viruses were those for colony-stimulating factor 3 (CSF3R) and IFN-γ.
“Among the inflammatory response genes dif-ferentially regulated by 1918 and H5N1 viruses were those for colony-stimulating factor 3 (CSF3R) and IFN-␥.”
Quote in the paperSubstantial claim - Premisecitation
The rapid and intense nature of the host inflammatory response is the suspected cause of severe lung damage.
“The rapid and intense nature of the host inflammatory response is the suspected cause of severe lung damage (116).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [116] source
Not checked in the free run.
- Premisecitation
RIG-I-deficient cells show reduced expression of IFN-alpha and -beta genes and IFN-stimulated genes during influenza virus infection.
“RIG-I-deficient cells show reduced expression of IFN-␣ and - genes as well as IFN-stimulated genes during influenza virus infection (91).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] source
Not checked in the free run.
- Premisecitation
RSV infection results in increased TLR4 expression on airway epithelial cells that sensitizes cells to endotoxin by enhancing LPS-receptor engagement.
“Similarly, respiratory syncytial virus (RSV) infection results in increased TLR4 expression on airway epithelial cells that sensitizes cells to endotoxin by enhancing LPS-receptor engagement (103), and TLR4 variants may attenuate innate immune responses by disrupting RSV triggering of TLR4 surface expression (142).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] source
Not checked in the free run.
- Premisereasoning
Plasmodium infection initiates IL-12 and IFN-gamma production, which enhances TLR expression and innate immune signaling pathways.
“Plasmodium infection initiates IL-12 and IFN-␥ production, which in turn enhances TLR expression and innate immune signaling pathways.”
Quote in the paperSubstantial claim - Interpretationcitation
Secondary effects of cytokine cascades, as opposed to the direct effect of the virus, in amplifying and broadening the proinflammatory response may be important in the escalation of cytokine storm.
“The concept of secondary effects of cytokine cascades, as opposed to the direct effect of the virus, in amplifying and broadening the proinflammatory response may be important in the escalation of cytokine storm (24,111,125).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
TNF is highly expressed across infection models, including primary human respiratory epithelial cells and human monocyte-derived macrophages, compared with seasonal H1N1 and swine-origin H1N1 influenza virus infection.
“It is highly expressed across infection models, including primary human respiratory epithelial cells (24, 125) and human monocyte-derived macrophages (26, 59, 62), compared with during seasonal H1N1 influenza virus and swine-origin H1N1 influenza virus (SOIV) infection (111).”
Quote in the paperSubstantial claim0 of 6 sources checked - Premisecitation
Variants of TLR4 can predispose individuals to sepsis, as evidenced by increased markers of systemic inflammation, including C-reactive protein (CRP), LPS-binding protein, and peripheral leukocytes in healthy humans exposed to endotoxin.
“Variants of TLR4, the principal receptor for lipopolysaccharide (LPS), can predispose individuals to sepsis, as evidenced by increased markers of systemic inflammation, including C-reactive protein (CRP), LPS-binding protein, and peripheral leukocytes in healthy humans exposed to endotoxin (99).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] source
Not checked in the free run.
- Premisecitation
Strong upregulation of IL-6, IL-8, CCL2, and CCL5 cytokine and chemokine gene expression in the lungs was mirrored by elevated levels of IL-8, CCL2, and CCL5 in the sera of infected animals.
“For example, strong upregulation of IL-6, IL-8, CCL2, and CCL5 cytokine and chemokine gene expression in the lungs was mirrored by elevated levels of IL-8, CCL2, and CCL5 in the sera of infected animals (78).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] source
Not checked in the free run.
- Premiseown data
A large portion of the differentially expressed inflammatory response genes were anticorrelated in gene expression (upregulated in 1918 virus-infected bronchial tissue but downregulated in H5N1 virus-infected bronchial tissue), including inflammasome genes NLRP3 and IL1B, cytokine genes TNF and IFNB1, and cytokine receptor genes TNFRSF1B and IL4R.
“A large portion of the differentially expressed inflammatory response genes were anticorrelated in gene expression (upregulated in 1918 virusinfected bronchial tissue but downregulated in H5N1 virusinfected bronchial tissue), including inflammasome genes NLRP3 and IL1B, cytokine genes TNF and IFNB1, and cytokine receptor genes TNFRSF1B and IL4R.”
Quote in the paperSubstantial claim - Premisecitation
TNF is one of the most prominent cytokines upregulated during H5N1 infection.
“TNF is one of the most prominent cytokines upregulated during H5N1 infection.”
Quote in the paperNot a substantial claim - Interpretationcitation
The paradigm of 'hit hard and hit early' popularized for the treatment of AIDS also appears to apply to the way H5N1 avian influenza virus causes tissue damage in human infections.
“The paradigm of “hit hard and hit early” popularized for the treatment of AIDS also appears to apply to the way H5N1 avian influenza virus causes tissue damage in human infections.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [116] source
Not checked in the free run.
- Interpretationreasoning
Over the past decade, compelling genomic evidence from animal model systems indicates that highly pathogenic influenza viruses aberrantly regulate cytokine and chemokine transcriptional responses, leading to a cytokine storm.
“Over the past decade, compelling genomic evidence from animal model systems indicates that highly pathogenic influenza viruses aberrantly regulate cytokine and chemokine transcriptional responses, leading to a cytokine storm.”
Quote in the paperSubstantial claim - Premisecitation
The phenomenon of enhanced TLR responsiveness was also observed in mice infected with Plasmodium chabaudi in a TLR9/IL-12/IFN-gamma-dependent manner.
“This phenomenon was also observed, in a TLR9/IL-12/IFN-␥-dependent manner, in mice infected with Plasmodium chabaudi (50).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] source
Not checked in the free run.
- Premisecitation
RIG-I is critical for type I IFN transcription during viral infection.
“RIG-I is critical for type I IFN transcription during viral infection (76).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] source
Not checked in the free run.
- Premisecitation
An overly aggressive innate immune response marked by early expression of proinflammatory cytokine genes was also observed in 1918 virus-infected macaques.
“An overly aggressive innate immune response marked by early expression of proinflammatory cytokine genes was also observed in 1918 virus-infected macaques (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
- Premisecitation
In a case study conducted in Ho Chi Minh City, Vietnam, comparing 18 people infected with H5N1 virus in 2004 and 2005 to 8 people infected with seasonal H1N1 influenza virus, elevated levels of MCP-1 (CCL2), IP-10 (CXCL10), MIG (CXCL9), and IL-8 were observed in H5N1 virus-infected patients who progressed to severe lung injury.
“In a case study conducted in Ho Chi Minh City, Vietnam, comparing 18 people infected with H5N1 virus in 2004 and 2005 to 8 people infected with seasonal H1N1 influenza virus, elevated levels of MCP-1 (known as CCL2), IFN-␥-inducible IP-10 (CXCL10), MIG protein (CXCL9), and IL-8 were observed in H5N1 virus-infected patients who progressed to severe lung injury (38).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] source
Not checked in the free run.
- Interpretationreasoning
A hyperresponsive TLR state represents one mechanism by which a cytokine storm can be perpetuated.
“A hyperresponsive TLR state represents one mechanism by which a cytokine storm can be perpetuated.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Increased TLR expression leads to a stage of hyperresponsiveness to TLR agonists.
- Interpretationcitation
The strong interferon and inflammatory transcriptional responses early in infection combined with histopathologic findings for H5N1-infected type II pneumocytes likely account for irreversible lung damage caused by inflammation.
“The strong interferon and inflammatory transcriptional responses early in infection combined with histopathologic findings for H5N1-infected type II pneumocytes likely account for irreversible lung damage caused by inflammation.”
Quote in the paperSubstantial claim - Premisecitation
In the absence of RIG-I signaling, mice fail to produce type I IFN in response to vesicular stomatitis virus, Newcastle disease virus, and Sendai virus infection.
“In the absence of RIG-I signaling, mice fail to produce type I IFN in response to vesicular stomatitis virus (VSV), Newcastle disease virus (NDV), and Sendai virus infection (74).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] source
Not checked in the free run.
- Interpretationreasoning
The host lung environment regulating inflammatory responses to infection may be dependent on the species, with swine having a more controlled environment for otherwise pathogenic influenza viruses.
“The host lung environment regulating inflammatory responses to infection may be dependent on the species, with swine having a more controlled environment for otherwise pathogenic influenza viruses.”
Quote in the paperSubstantial claim - Premisecitation
TLR4 variants may attenuate innate immune responses by disrupting RSV triggering of TLR4 surface expression.
“and TLR4 variants may attenuate innate immune responses by disrupting RSV triggering of TLR4 surface expression (142).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142] source
Not checked in the free run.
- Premisereasoning
In humans acutely infected with Plasmodium falciparum, enhanced activation of innate immune cells to TLR agonists was observed.
“This was observed in humans acutely infected with Plasmodium falciparum, resulting in enhanced activation of innate immune cells to TLR agonists.”
Quote in the paperSubstantial claim - Interpretationcitation
These genomic data suggested that the host response enhances 1918 virus pathogenesis by initiating a cytokine storm that contributes to increased disease severity.
“These genomic data suggested that the host response enhances 1918 virus pathogenesis by initiating a cytokine storm that contributes to increased disease severity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] source
Not checked in the free run.
- Premisecitation
Extensive lung damage in mice infected with 1918 virus was accompanied by highly upregulated cytokine and chemokine gene expression.
“Extensive lung damage in mice infected with 1918 virus was accompanied by highly upregulated cytokine and chemokine gene expression (73).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] source
Not checked in the free run.
- Premisecitation
Recent studies have shown a vast amount of variability in the innate immune responses of healthy humans, as reflected by the intermediate phenotype of whole-blood cytokine responses to bacterial products.
“Recent stud- ies have shown a vast amount of variability in the innate immune responses of healthy humans, as reflected by the intermediate phenotype of whole-blood cytokine responses to bacterial products (151).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [151] source
Not checked in the free run.
- Premisecitation
Genomic studies of SARS-CoV infection in ferrets showed enhanced expression of chemokine ligands, in particular CCL2, CCL4, CCL14, CCL19, and CCL25.
“Genomic studies of SARS-CoV infection in ferrets showed enhanced expression of chemokine ligands, in particular, CCL2, CCL4, CCL14, CCL19, and CCL25 (37).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] source
Not checked in the free run.
- Premisecitation
Differential chemokine expression is observed in viral lung disease caused by respiratory syncytial virus.
“In addition to playing a distinct role in the early clinical course and persistence of SARS in infected patients, differential chemokine expression is observed in viral lung disease caused by respiratory syncytial virus (RSV) (36).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] source
Not checked in the free run.
- Premisecitation
Upregulation of the fibrosis-associated chemokine CCL2 was shown to be mediated by ERK1/2 in human lung A549 epithelial cells incubated with SARS-CoV spike protein or SARS virus-like particles.
“Upregulation of the fibrosis-associated chemokine CCL2 was shown to be mediated by ERK1/2 in human lung A549 epithelial cells incubated with SARS-CoV spike (S) protein or SARS virus-like particles (VLPs) (25).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] source
Not checked in the free run.
- Premisecitation
Cytokine signaling pathway redundancy is also observed with respect to type I IFN signaling, as there is strong upregulation of IFN-stimulated gene expression in IFN-alpha/betaR KO mice infected with the 1918 virus.
“Cytokine signaling pathway redundancy is also observed with respect to type I IFN signaling, as there is strong upregulation of IFN-stimulated gene expression in IFN-␣/R KO mice infected with the 1918 virus (27).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] source
Not checked in the free run.
- Premisecitation
Teijaro and colleagues demonstrated that blunted innate chemokine and cytokine responses mediated by S1P1-selective agonists protected mice from lethal infection with pandemic H1N1 influenza virus.
“Teijaro and colleagues (139) demonstrated that blunted innate chemokine and cytokine responses mediated by S1P 1 -selective agonists protected mice from lethal infection with pandemic H1N1 influenza virus.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [139] source
Not checked in the free run.
- Premisecitation
Gene expression signatures for type I and type II IFN responses in the lungs of SARS patients revealed persistent expression of CXCL10, CCL2, IFNAR1, IFNGR1, and CD58.
“Gene expression signatures for type I and type II IFN responses in the lungs of SARS patients revealed persistent expression of CXCL10, CCL2, IFNAR1, IFNGR1, and CD58.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
- Interpretationcitation
Atypical IFN-mediated immune responses suggest that type I IFN signaling may be important in the pathogenesis of SARS-CoV.
“Atypical IFNmediated immune responses suggest that type I IFN signaling may be important in the pathogenesis of SARS-CoV (21).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
- Premisecitation
Gene expression studies have shown that type I IFN-inducible transcripts are the most prominent overabundant family of transcripts in blood leukocytes in the early acute phase of dengue relative to the late convalescence phase.
“Gene expression studies have shown that type I IFN-inducible transcripts are the most prominent overabundant family of transcripts in blood leukocytes in the early acute phase of dengue relative to the late convalescence phase (60).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Premisecitation
Serum concentrations of IFN-alpha, IFN-gamma, IL-10, and TNF receptors are elevated in the early phase of dengue and remain elevated until defervescence occurs.
“Serum concentrations of IFN-␣, IFN-␥, IL-10, and TNF receptors are elevated in this early phase and remain elevated until defervescence occurs (86).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86] source
Not checked in the free run.
- Premisecitation
Combination therapy consisting of zanamvir, an inhibitor of the influenza virus neuraminidase, and celecoxib and mesalazine, inhibitors of inflammation, increased the survival of mice infected with a highly pathogenic strain of H5N1 influenza virus.
“Combination therapy consisting of zanamvir, an inhibitor of the influenza virus neuraminidase, and celecoxib and mesalazine, inhibitors of inflammation, increased the survival of mice infected with a highly pathogenic strain of H5N1 influenza virus (157).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [157] source
Not checked in the free run.
- Premisecitation
The majority of antimalarial drugs sold in Africa are either ineffective or accelerate malarial parasite resistance owing to the distribution of counterfeit drugs.
“The majority of antimalarial drugs sold in Africa are either ineffective or accelerate malarial parasite resistance owing to the distribution of counterfeit drugs (9,43).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
Agonism of S1P1 receptor has no effect on viral replication.
“Agonism of S1P 1 receptor has no effect on viral replication; however, some strategies dampening the immune response can correlate with increased susceptibility to infection.”
Quote in the paperSubstantial claim - Interpretationcitation
These studies demonstrated that antiviral treatment was less effective alone than in combination with immunomodulatory therapies that suppressed inflammation.
“These studies demonstrated that antiviral treatment was less effective alone than in combination with immunomodulatory therapies that suppressed inflammation.”
Quote in the paperSubstantial claim - Premisecitation
The COX-2 inhibitors celecoxib and mesalazine also reduced the mortality rate of mice infected with H5N1 influenza virus when administered in combination with zanamivir.
“The cyclooxygenase-2 (COX-2) inhibitors celecoxib and mesalazine also reduced the mortality rate of mice infected with H5N1 influenza virus when administered in combination with zanamivir (22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] source
Not checked in the free run.
- Premisecitation
The transcriptional response in IL1R KO mice during acute infection is strongly associated with an increase in TNF gene expression, revealing the interplay between IL-1 and TNF proinflammatory mediators.
“The transcriptional response in IL1R KO mice during acute infection is strongly associated with an increase in TNF gene expression, revealing the interplay between IL-1 and TNF proinflammatory mediators (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] source
Not checked in the free run.
- Premisecitation
Immunomodulatory drugs that diminish inflammation during infection with drug treatment show therapeutic benefit.
“Immunomodulatory drugs that diminish inflammation during infection with drug treatment show therapeutic benefit (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Premisecitation
Elevated concentrations of TNF-RII predict severe dengue in children.
“Elevated concentrations of TNF-RII predict severe dengue in children (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
- Premisenone given
In the absence of TNF, mice showed an increase in survival that was associated with a decrease in IFN-signaling-related antiviral gene expression.
“In the absence of TNF, mice showed an increase in survival that was associated with a decrease in IFNsignaling-related antiviral gene expression.”
Quote in the paperNot a substantial claim - Premisenone given
T-cell responses in severely ill dengue patients are limited, in that they produce IFN-gamma and/or TNF and rarely CD107a, a marker of cytotoxic degranulation.
“In particular, T-cell responses in severely ill patients are limited, in that they produce IFN-␥ and/or TNF and rarely CD107a, a marker of cytotoxic degranulation.”
Quote in the paperSubstantial claim - Premisecitation
S1P receptor 1 suppresses immune cell recruitment through downregulation of cytokine and chemokine production by respiratory endothelial cells in the presence of S1P1-selective agonists, CYM-5442 and RP-002, including production of IFN-alpha, CCL2, IL-6, TNF-alpha, and IFN-gamma.
“Sphingosine-1-phosphate (S1P) receptor 1 suppresses immune cell recruitment through downregulation of cytokine and chemokine production by respiratory endothelial cells in the presence of S1P 1 -selective agonists, CYM-5442 and RP-002, including production of IFN-␣, CCL2, IL-6, TNF-␣, and IFN-␥, (139).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [139] source
Not checked in the free run.
- Premisecitation
PPAR-gamma agonists downregulate the inflammatory response to virus-induced lung inflammation.
“PPAR-␥ agonists downregulate the inflammatory response to virus-induced lung inflammation (8).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] source
Not checked in the free run.
- Premisecitation
Characterization of a recombinant mouse-adapted SARS-CoV strain rMA15 in STAT1 knockout mice revealed increased pathology in the absence of STAT1 signaling, including evidence of pulmonary fibrotic lesions.
“Characterization of a recombinant mouse-adapted SARS-CoV strain (rMA15) in STAT1 knockout mice revealed increased pathology in the absence of STAT1 signaling, including evidence of pulmonary fibrotic lesions (52).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] source
Not checked in the free run.
- Premisecitation
Some strategies dampening the immune response can correlate with increased susceptibility to infection.
“however, some strategies dampening the immune response can correlate with increased susceptibility to infection.”
Quote in the paperSubstantial claim - Premisecitation
Sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus.
“and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] source
Not checked in the free run.
- Premisecitation
Sphingosine receptors play an important role in innate immune responses.
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] source
Not checked in the free run.
- Premisenone given
Enhanced antiviral gene expression to SARS-CoV in IFNAR KO mice suggested that alternate signaling pathways were compensating for the lack of type I IFN signaling through IFNAR, possibly Jak-STAT signaling activated by type III IFNs.
“Enhanced antiviral gene expression to SAR-CoV in IFNAR KO mice suggested that alter- nate signaling pathways were compensating for the lack of type I IFN signaling through IFNAR, possibly Jak-STAT signaling activated by type III IFNs.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Dampening an overactive proinflammatory response is not as straightforward as targeting the key cytokine mediators, since most chemokine receptors bind several ligands and contain small ligand binding pockets that have proved difficult to identify effective antagonists.
“However, dampening an overactive proinflammatory response is not as straightforward as targeting the key cytokine mediators, since most chemokine receptors, for example, bind several ligands and contain small ligand binding pockets that have proved difficult to identify effective antagonists.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The VEGF axis may be an important mechanism of plasma leakage in severe dengue.
“This, together with dengue virus-induced changes to endothelial cell VEGFR2 surface expression and responsiveness to VEGF stimulation, has led to the suggestion that the VEGF axis may be an important mechanism of plasma leakage in severe dengue.”
Quote in the paperSubstantial claim - Interpretationreasoning
It is likely that during a severe acute infection, certain elements of the immune response need enhancing at times and need suppressing at other times.
“In simple terms, it is likely that during a severe acute infection, certain elements of the immune response need enhancing at times and need suppressing at other times.”
Quote in the paperSubstantial claim - Interpretationreasoning
Treating patients with the right immunomodulating drug but at the wrong time could worsen the clinical outcome.
“Treating patients with the “right” immunomodulating drug but at the “wrong” time could worsen the clinical outcome.”
Quote in the paperSubstantial claim - Interpretationreasoning
Once initiated, the proinflammatory cytokines and chemokines can continue to drive the progression of immunopathologic events in the absence of continued viral replication.
“Once initiated, the proinflammatory cytokines and chemokines can continue to drive the progression of immunopathologic events in the absence of continued viral replication.”
Quote in the paperSubstantial claim - Interpretationreasoning
Variations in host response are likely to be complex and controlled by host and pathogen genetic determinants as well as by the immune memory of each individual.
“These variations in host response are likely to be complex and controlled by host and pathogen genetic determinants as well as by the immune memory of each individual.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 38
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe cytokine storm is best exemplified by severe lung infections, in which local inflammation spills over into the systemic circulation, producing systemic sepsis, as defined by persistent hypotension, hyper-or hypothermia, leukocytosis or leukopenia, and often thrombocytopenia.
“The cytokine storm is best exemplified by severe lung infections, in which local inflammation spills over into the systemic circulation, producing systemic sepsis, as defined by persistent hypotension, hyper-or hypothermia, leukocytosis or leukopenia, and often thrombocytopenia (84).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84]
Not checked in the free run.
- Rests on an assumption: Inflammation associated with a cytokine storm begins at a local site and spreads throughout the body via the systemic circulation.
May combine two claims.
PremisecitationIL-1 receptor signaling is responsible for acute lung immunopathology but increases the survival of mice infected with influenza virus by enhancing IgM antibody responses and recruiting CD4+ T cells to the site of infection.
“IL-1 receptor signaling is responsible for acute lung immunopathology but increases the survival of mice infected with influenza virus by enhancing IgM antibody responses and recruiting CD4 ϩ T cells to the site of infection (124).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124]
Not checked in the free run.
May combine two claims.
PremisecitationThe use of TNF inhibitors for the treatment of sepsis has not been successful, possibly due to the early release and short circulating half-life of the cytokine.
“In contrast, the use of TNF inhibitors for the treatment of sepsis has not been successful (49), possibly due to the early release and short circulating half-life of the cytokine (30).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [49]
Not checked in the free run.
- cites [30]
Not checked in the free run.
May combine two claims.
PremisecitationThe acute-response cytokines TNF and IL-1β and the chemotactic cytokines IL-8 and MCP-1 appear in the early minutes to hours after infection, followed by a more sustained increase in IL-6.
“The acute-response cytokines TNF and IL-1 and the chemotactic cytokines IL-8 and MCP-1 appear in the early minutes to hours after infection, followed by a more sustained increase in IL-6.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [138]
Not checked in the free run.
- cites [136] source
Not checked in the free run.
- cites [1]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIf one or more regulatory mechanisms of lung inflammation are absent or aberrantly regulated, then the outcome may contribute toward a cytokine storm.
“As the balance of pro-and anti-inflammatory mechanisms is critical to maintaining lung immune homeostasis, it is conceivable that if one or more of these regulatory mechanisms are absent or aberrantly regulated, then the outcome may contribute toward a cytokine storm.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenStudies of patients with severe sepsis due to pulmonary or nonpulmonary infections show characteristic plasma cytokine profiles, which change over time.
“Studies of patients with severe sepsis due to pulmonary or nonpulmonary infections show characteristic plasma cytokine profiles, which change over time.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAcute lung injury (ALI) is a common consequence of a cytokine storm in the lung alveolar environment and systemic circulation and is most commonly associated with suspected or proven infections in the lungs or other organs.
“Acute lung injury (ALI) is a common consequence of a cytokine storm in the lung alveolar environment and systemic circulation and is most commonly associated with suspected or proven infections in the lungs or other organs (121).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [121]
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 concentrations in peripheral blood have been used to assess the intensity of systemic cytokine responses in patients with sepsis, because IL-6 production is stimulated by TNF and IL-1β, providing an integrated signal of these two early-response cytokines.
“IL-6 concentrations in peripheral blood have been used to assess the intensity of systemic cytokine responses in patients with sepsis, because IL-6 production is stimulated by TNF and IL-1, providing an integrated signal of these two early-response cytokines (1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1]
Not checked in the free run.
May combine two claims.
PremisecitationPatients with persistent downregulation of HLA-DR on monocytes 3 to 4 days after the onset of severe sepsis and cytokine storm have a high mortality rate, suggesting a rationale for therapy to reverse immunosuppression under such circumstances.
“Patients with persistent downregulation of HLA-DR (a marker of immunosuppression) on monocytes 3 to 4 days after the onset of severe sepsis and cytokine storm have a high mortality rate, suggesting a rationale for therapy to reverse immunosuppression under such circumstances (104).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104]
Not checked in the free run.
May combine two claims.
Premiseown dataDirect comparison of transcriptional responses in infected macaque bronchi showed that these viruses induce similar IFN-regulated gene expression patterns, while genes associated with inflammation were significantly differentially regulated by 1918 and H5N1 viruses.
“Direct comparison of transcriptional responses in infected macaque bronchi showed that these viruses induce similar IFNregulated gene expression patterns, while genes associated with inflammation were significantly differentially regulated by 1918 and H5N1 viruses.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPigs infected with contemporary H1N1 viruses experienced a transient, early increase in immune response concurrent with greater clinical illness, including greater expression of cytokines and chemokines such as TNF, TNFR, CXCL10, IFN-beta, IL-12alpha, and IFN-related signaling molecules.
“Pigs infected with the contemporary viruses experienced a transient, early increase in immune response concurrent with greater clinical illness.This included greater expression of cytokines and chemokines such as TNF, TNFR, CXCL10, IFN-, IL-12␣, and IFNrelated signaling molecules.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [93]
Not checked in the free run.
May combine two claims.
PremisecitationIn a study led by Belisle and colleagues, IL-1R and TNFR KO mice infected with the 1918 virus showed a protective role for IL-1alpha, while TNF exerted adverse cytokine storm effects.
“In a study led by Belisle and colleagues, IL-1R and TNFR KO mice infected with the 1918 virus showed a protective role for IL-1␣, while TNF exerted adverse cytokine storm effects.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningDifferent influenza viruses may present agonists accounting for differential host proinflammatory responses to infection.
“Different influenza viruses may present agonists accounting for differential host proinflammatory responses to infection.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTNF is not directly induced in respiratory epithelial cells by influenza virus infection but is induced by secondary mediator cascades distinct from the primary effects of the virus.
“While a range of proinflammatory cytokines are induced in respiratory epithelial cells, TNF is not directly induced in respiratory epithelial cells by influenza virus infection (24) but rather is induced by secondary mediator cascades distinct from the primary effects of the virus (83).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Not checked in the free run.
- cites [83]
Not checked in the free run.
May combine two claims.
PremisecitationHyper-and hyporesponders to bacterial products are identifiable in the healthy population, which is explainable in part by genetically determined differences in the structure and function of TLR receptors, particularly TLR1.
“Hyper-and hyporesponders to bacterial products are identifiable in the healthy population, which is explainable in part by genetically determined differences in the structure and function of TLR receptors, particularly TLR1 (150).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150]
Not checked in the free run.
May combine two claims.
PremisecitationTranscriptional activation of innate immune genes was observed as early as 1 day postinfection and remained sustained through the course of infection.
“Transcriptional activation of innate immune genes was observed as early as 1 day postinfection and remained sustained through the course of infection.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73]
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe upregulation of cytokines associated with the cytokine storm likely varies between pigs and macaques, potentially in the kinetics of PRR stimulation, allowing the pig to serve as a reservoir for influenza viruses with pathogenic potential.
“The upregulation of these cytokines associated with the cytokine storm likely varies between pigs and macaques, potentially in the kinetics of PRR stimulation, allowing the pig to serve as a reservoir for influenza viruses with pathogenic potential.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral GWAS have also identified variants of IFN-3 that were associated with spontaneous resolution and successful treatment of hepatitis C virus (HCV) infection.
“Several GWAS have also identified variants of IFN-3 that were associated with spontaneous resolution and successful treatment of hepatitis C virus (HCV) infection (55,140).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [55]
Not checked in the free run.
- cites [140]
Not checked in the free run.
May combine two claims.
PremisecitationIn contrast to lethal influenza virus infection in other animal models, the increased cytokine and chemokine gene expression in pigs resolved and all pigs recovered.
“In contrast to the case for lethal influenza virus infection in other animal models, the increased cytokine and chemokine gene expression resolved and all pigs recovered.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [93]
Not checked in the free run.
May combine two claims.
PremisecitationIFN signaling appears to play a critical role in restricting highly pathogenic influenza viruses to the lung microenvironment, as IFNAR deficiency in mice results in dissemination of the 1918 virus to brain and spleen.
“IFN signaling appears to play a critical role in restricting highly pathogenic influenza viruses to the lung microenvironment, as IFNAR deficiency in mice results in dissemination of the 1918 virus to brain and spleen (27).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27]
Not checked in the free run.
May combine two claims.
PremisecitationTLR4 Asp299Gly occurred at a high frequency in Ghanaian children with severe malaria, and the polymorphism was also associated with manifestation of malaria during pregnancy in Ghanaian women.
“For example, TLR4 Asp299Gly occurred at a high frequency in Ghanaian children with severe malaria (100), and the polymorphism was also associated with manifestation of malaria during pregnancy in Ghanaian women (101).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [100]
Not checked in the free run.
- cites [101]
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese findings suggest that an accelerated or excessive activation of the inflammasome is detrimental rather than protective in macaques infected with 1918 virus and that dysregulation of type I IFN signaling genes may impact regulation of inflammasome activity.
“These findings suggest that an accelerated or excessive activation of the inflammasome is detrimental rather than protective in macaques infected with 1918 virus and that dysregulation of type I IFN signaling genes may impact regulation of inflammasome activity.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationT cells are potent contributors of cytokines to the inflammatory milieu in infected tissues and this contributes to vasodilation during the critical phase of dengue illness, although not all studies have found evidence in support of this hypothesis.
“These and other data (102) suggest that T cells are potent contributors of cytokines to the inflammatory milieu in infected tissues and that this contributes to vasodilation during this critical phase of the illness, although not all studies have found evidence in support of this hypothesis (44).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [102]
Not checked in the free run.
- cites [44]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenAnother consequence of the cytokine storm in dengue virus infection is an increased capillary permeability syndrome.
“Another consequence of the cytokine storm in dengue virus infection is an increased capillary permeability syndrome.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenOne characteristic feature of SARS is the development of pulmonary fibrosis, observed with inflammation and hypercytokinemia.
“One characteristic feature of SARS is the development of pulmonary fibrosis, observed with inflammation and hypercytokinemia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDespite efforts to target the host response with anti-inflammatory drugs and adjunct approaches in acute severe infections, none has been proved effective, and some have worsened the outcome.
“Despite these efforts, none has been proved to be effective (98), and some have worsened the outcome (19).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [98]
Not checked in the free run.
- cites [19]
Not checked in the free run.
May combine two claims.
Premisenone givenIn patients with uncomplicated dengue, relatively more CD8+ T cells display CD107a and few express only IFN-gamma and/or TNF.
“Conversely, in patients with uncomplicated dengue, relatively more CD8 ϩ T cells display CD107a and few express only IFN-␥ and/or TNF.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenIncreased capillary permeability in dengue usually occurs between days 4 and 6 of illness, is transient, and only occasionally results in hypovolemic shock.
“Increased capillary permeability in dengue usually occurs between days 4 and 6 of illness, is transient, and only occasionally results in hypovolemic shock.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenSevere dengue occurs most commonly in individuals experiencing a second infection with a serotype distinct from that of a past exposure.
“Intriguingly, severe dengue occurs most commonly in individuals experiencing a second infection with a serotype distinct from that of a past exposure.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAt the stage of increased capillary permeability in dengue, viremia is in steep decline and serum cytokine concentrations of IFN-gamma and IL-10 are at or near their peak levels.
“At this stage of the illness, viremia is in steep decline and serum cytokine concentrations of IFN-␥ and IL-10 are at or near their peak levels (86).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenMost permeability-inducing factors bind to endothelial cell plasma membrane receptors, activate heterotrimeric G proteins, and cause an increase in intracellular Ca2+, resulting in myosin-driven endothelial contraction and opening of tight junctions.
“Most permeability-inducing factors bind to endothelial cell plasma membrane receptors, activate heterotrimeric G proteins, and cause an increase in intracellular Ca 2ϩ .This results in myosin-driven endothelial contraction and opening of tight junctions.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationGemfibrozil targets PPARalpha, dampening the inflammatory response and improving the survival of mice infected with influenza H2N2 virus.
“For example, gemfibrozil targets PPAR␣, dampening the inflammatory response and improving the survival of mice infected with influenza H2N2 virus (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20]
Not checked in the free run.
May combine two claims.
PremisecitationHigh plasma levels of the IFN-stimulated chemokines CXCL10 and CCL2 were found in SARS patients, and those who died from infection exhibited significantly higher levels of CXCL10 than those who recovered.
“High plasma levels of the IFNstimulated chemokines CXCL10 and CCL2 were found in infected patients, and those who died from infection exhibited significantly higher levels of CXCL10 than those who recovered.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21]
Not checked in the free run.
May combine two claims.
PremisecitationIn vivo, plasma levels of free but not total VEGF-A are elevated in severely ill dengue patients at the time of plasma leakage, while VEGFR2 levels are diminished.
“In vivo, plasma levels of free but not total VEGF-A are elevated in severely ill patients at the time of plasma leakage, while VEGFR2 levels are diminished (134).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134]
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenTo date, successful targeting of the immune system during acute infections has proved to be extraordinarily difficult and largely unsuccessful.
“Yet to date, successful targeting of the immune system during acute infections has proved to be extraordinarily difficult and largely unsuccessful.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationGene expression analysis of primary human cells infected with dengue virus revealed strong upregulation of CCL8 and CXCL10, and these proteins were increased in infected patients during the febrile period of the disease.
“Gene expression analysis of primary human cells infected with dengue virus revealed strong upregulation of CCL8 and CXCL10, and these proteins were increased in infected patients during the febrile period of the disease (10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10]
Not checked in the free run.
May combine two claims.
PremisecitationMicroarray profiling showed a skewing toward Th2 responses that was influenced by the absence of STAT1 signaling and likely accounted for the protein deposition in the lungs.
“In particular, microarray profiling showed a skewing toward Th2 responses that was influenced by the absence of STAT1 signaling and likely accounted for the protein deposition in the lungs (158).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158]
Not checked in the free run.
May combine two claims.
PremisecitationIn mice treated with DNA encoding transforming growth factor beta1, pulmonary eosinophilic responses were inhibited yet susceptibility to Cryptococcus neoformans, influenza virus, and respiratory syncytial virus was increased.
“This was observed in mice treated with DNA encoding transforming growth factor 1 (TGF-1), which inhibited pulmonary eosinophilic responses yet increased susceptibility to Cryptococcus neoformans, influenza virus, and respiratory syncytial virus (147).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [147]
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationPeroxisome proliferator-activated receptors are lipid-activated transcription factors that act as key regulators of lipid metabolism and inflammation.
“Peroxisome proliferator-activated receptors (PPARs) are lipidactivated transcription factors that act as key regulators of lipid metabolism and inflammation (reviewed in reference 12).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12]
Not checked in the free run.
May combine two claims.
Premisenone givenPrevious trials of corticosteroids in dengue have involved patients with hypovolemic shock and did not show benefit, though this could have reflected the late timing of therapy.
“Previous trials of corticosteroids have involved patients with hypovolemic shock and did not show benefit, though this could have reflected the late timing of therapy.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenDespite strong evidence of a cytokine storm in many severe acute infections, it has proven difficult to intervene and improve clinical outcomes, for reasons that remain elusive.
“Nevertheless, despite strong evidence of a cytokine storm in many severe acute infections, it has proven difficult to intervene and improve clinical outcomes, for reasons that remain elusive.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationMany acute infections are characterized by a powerful and potentially destructive immune response, and it would seem logical to target this response in order to reduce the self-inflicted damage initiated by the host in response to infection.
“As we have discussed, many acute infections are characterized by a powerful and potentially destructive immune response, and it would seem logical to target this response in order to reduce the self-inflicted damage initiated by the host in response to infection (129).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [129]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenGenomic studies have revealed chemokine gene expression and regulation patterns that can impact Th1- and Th2-biased immunopathology.
“Genomic studies have revealed chemokine gene expression and regulation patterns that can impact Th1-and Th2biased immunopathology.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenThe world of host and pathogen genetics has been revolutionized in the last decade, and through scale and increasingly sophisticated biostatistical analysis, what associations mean and how they should be interpreted will continue to be developed.
“The world of host and pathogen genetics has been revolutionized in the last decade, and through scale and increasingly sophisticated biostatistical analysis, what associations mean and how they should be interpreted will continue to be developed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
Premisenone givenWe have split interdependent systems into silos of research such that studies of the immune cascade rarely integrate the pathogen or the host genetic makeup or attempt to interrogate the whole delicate and rapidly changing immune environment.
“Moreover, we have split interdependent systems into silos of research such that studies of the immune cascade rarely integrate the pathogen or the host genetic makeup or attempt to interrogate the whole delicate and rapidly changing immune environment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Premisenone givenThe development of transcriptional signatures and proteomics to complement host and pathogen genetic studies is providing great steps forward; however, integrated studies need to be standardized with much tighter definitions of the clinical and phenotypic data.
“The development of transcriptional signatures and proteomics to complement host and pathogen genetic studies is providing great steps forward; however, we need to standardize these integrated studies with much tighter definitions of the clinical and phenotypic data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenNext-generation sequencing has unveiled a more comprehensive view of the transcriptome, enabling identification of large and small RNAs, splice isoforms, and novel transcripts from unannotated genes.
“For example, NGS has unveiled a more comprehensive view of the transcriptome, enabling identification of large and small RNAs, splice isoforms, and novel transcripts from unannotated genes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe need for better methods for NGS data analysis, including RNA-Seq bias correction and improved isoform quantification, is one of the challenges faced with using this technology.
“Overall, the need for better methods for NGS data analysis, including RNA-Seq bias correction and improved isoform quantification, is just one of the challenges faced with using this technology.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIndividuals respond differently to infection and individual responses to antibiotics and adjunct therapies also vary.
“We know that individuals respond differently to infection and that individual responses to antibiotics and adjunct therapies also vary (141).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141]
Not checked in the free run.
The paper relies on this without support.
An actual definition of what constitutes a cytokine storm is lacking.
“an actual definition of what constitutes a cytokine storm is lacking”
The paper relies on this without support.
There is not a good understanding of the molecular events that precipitate a cytokine storm, of the contribution such a storm makes to pathogenesis, or of what therapeutic strategies might be used to prevent or quell it.
“there is not a good understanding of the molecular events that precipitate a cytokine storm, of the contribution such a “storm” makes to pathogenesis, or of what therapeutic strategies might be used to prevent the storm or quell it once it has started.”
The paper relies on this without support.
We still do not understand the complex nature of the immune response and have probably underestimated its dynamic nature during acute infection.
“We still do not understand the complex nature of the immune response and have probably underestimated its dynamic nature during acute infection.”
The paper relies on this without support.
Inflammation associated with a cytokine storm begins at a local site and spreads throughout the body via the systemic circulation.
“Inflammation associated with a cytokine storm begins at a local site and spreads throughout the body via the systemic circulation.”
The paper relies on this without support.
TNF is a central cytokine in acute viral diseases, including those caused by influenza virus, dengue virus, and Ebola virus.
“TNF is now considered a central cytokine in acute viral diseases, including those caused by influenza virus, dengue virus, and Ebola virus.”
The paper relies on this without support.
There are no animal models that mimic the clinical syndrome of severe dengue in humans.
“There are no animal models that mimic the clinical syndrome of severe dengue in humans, and therefore observational studies of patient cohorts are the main source of understanding the immunopathogenesis of dengue virus infections.”
The authors state this as an assumption.
The host anamnestic immune response mechanistically contributes to the syndrome of increased capillary permeability that characterizes severe dengue.
“In these so-called heterotypic infections, the host anamnestic immune response is postulated to mechanistically contribute to the syndrome of increased capillary permeability that characterizes severe dengue.”
The authors state this as an assumption.
Increased TLR expression leads to a stage of hyperresponsiveness to TLR agonists.
“The increased TLR expression is thought to lead to a stage of hyperresponsiveness to TLR agonists.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cytokine storms have been reported in several viral infections, including SARS-CoV-2.
“Cytokine storms have been reported in several viral infections [96], including SARS-CoV-2 [9, 97].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [96]
Cites
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,730 · see citing works
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · see citing works
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · see citing works
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E. H., Angus, D. C., Cook, D., Cohen, J., Opal, S. M., Vincent, J., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,976 · see citing works
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854 · see citing works
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · see citing works
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · see citing works
Incidence and Outcomes of Acute Lung Injury
Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., & Hudson, L. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050333 · Cited by 3,684 · see citing works
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,510 · see citing works
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · see citing works
Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · see citing works
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,244 · see citing works
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · see citing works
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742 · see citing works
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562 · see citing works
Beutler, B., Milsark, I. W., & Cerami, A. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,369 · see citing works
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · see citing works
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147 · see citing works
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875 · see citing works
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858 · see citing works
Self-citationAnimal models of acute lung injury
Matute‐Bello, G., Frevert, C. W., & Martin, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00010.2008 · Cited by 1,744 · see citing works
Self-citationIL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P. O., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R. E., Garrigues, U., Birks, C., Roraback, J., et al. (2002) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,563 · see citing works
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature reviews. Immunology · doi:10.1038/nri2691 · Cited by 1,416 · see citing works
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · see citing works
Influenza virus receptors in the human airway
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., & Kawaoka, Y. (2006) · Nature · doi:10.1038/440435a · Cited by 1,398 · see citing works
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368 · see citing works
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356 · see citing works
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · see citing works
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227 · see citing works
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,208 · see citing works
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190 · see citing works
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154 · see citing works
Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity
Loo, Y.-M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M. A., García-Sastre, A., Katze, M. G., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01080-07 · Cited by 1,071 · see citing works
Self-citationCXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,006 · see citing works
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934 · see citing works
Self-citationType I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Pasquier, R. D., Romero, P. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 924 · see citing works
Cheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889 · see citing works
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland‐Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 822 · see citing works
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
Moyron‐Quiroz, J., Rangel‐Moreno, J., Kusser, K. L., Hartson, L., Sprague, F., Goodrich, S. P., Woodland, D. L., Lund, F. E., & Randall, T. D. (2004) · Nature Medicine · doi:10.1038/nm1091 · Cited by 815 · see citing works
Integration of metabolism and inflammation by lipid-activated nuclear receptors
Bensinger, S. J., & Tontonoz, P. (2008) · Nature · doi:10.1038/nature07202 · Cited by 813 · see citing works
Re-emergence of fatal human influenza A subtype H5N1 disease
Peiris, J., Yu, W., Leung, C., Cheung, C., Ng, W., Nicholls, J., Ng, T., Chan, K., Lai, S., Lim, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15595-5 · Cited by 812 · see citing works
Activation of innate immune antiviral responses by Nod2
Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V. C., Tominaga, K., Dube, P. H., Xiang, Y., & Bose, S. (2009) · Nature Immunology · doi:10.1038/ni.1782 · Cited by 754 · see citing works
Nawroth, P. P., Bank, I., Handley, D. A., Cassimeris, J., Chess, L., & Stern, D. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.6.1363 · Cited by 692 · see citing works
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688 · see citing works
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679 · see citing works
The alliance of sphingosine-1-phosphate and its receptors in immunity
Rivera, J., Proia, R. L., & Olivera, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2400 · Cited by 616 · see citing works
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus
Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551 · see citing works
Self-citationPersisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
Monneret, G., Lepape, A., Voirin, N., Bohé, J., Venet, F., Debard, A., Thizy, H., Bienvenu, J., Gueyffier, F., & Vanhems, P. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0204-8 · Cited by 549 · see citing works
Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome
PARK, W. Y., GOODMAN, R. B., STEINBERG, K. P., RUZINSKI, J. T., RADELLA, F., PARK, D. R., PUGIN, J., SKERRETT, S. J., HUDSON, L. D., & MARTIN, T. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104013 · Cited by 547 · see citing works
Self-citationThe lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., Hagge, D. A., Khadge, S., King, M., Hawn, T. R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.013 · Cited by 529 · see citing works
Regulation of immunological homeostasis in the respiratory tract
Holt, P. G., Strickland, D. H., Wikström, M. E., & Jahnsen, F. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2236 · Cited by 528 · see citing works
Normal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive
Munford, R. S., & Pugin, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2007102 · Cited by 520 · see citing works
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
Finck‐Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener‐Kronish, J. P., Fleiszig, S. M. J., Wu, C. C., Mende‐Mueller, L., & Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4891851.x · Cited by 518 · see citing works
Chan, M., Cheung, C., Chui, W., Tsao, S., Nicholls, J., Chan, Y., Chan, R., Long, H., Poon, L., Guan, Y., et al. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-135 · Cited by 510 · see citing works
Molecular basis of group A streptococcal virulence
Bisno, A. L., Brito, M. O., & Collins, C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00576-0 · Cited by 505 · see citing works
Libraty, D. H., Endy, T. P., Houng, H. H., Green, S., Kalayanarooj, S., Suntayakorn, S., Chansiriwongs, W., Vaughn, D. W., Nisalak, A., Ennis, F. A., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340365 · Cited by 494 · see citing works
A question of self‐preservation: immunopathology in influenza virus infection
Gruta, N. L. L., Kedzierska, K., Stambas, J., & Doherty, P. C. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100026 · Cited by 454 · see citing works
A critical function for CD200 in lung immune homeostasis and the severity of influenza infection
Snelgrove, R. J., Goulding, J., Didierlaurent, A. M., Lyonga, D., Vekaria, S., Edwards, L., Findlay, E. G., Sedgwick, J. D., Barclay, A. N., & Hussell, T. (2008) · Nature Immunology · doi:10.1038/ni.1637 · Cited by 454 · see citing works
Lin, K. L., Suzuki, Y. A., Nakano, H., Ramsburg, E. A., & Gunn, M. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2562 · Cited by 441 · see citing works
Wang, H., & Ma, S. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2007.10.031 · Cited by 408 · see citing works
Interferons and viral infections
Fensterl, V., & Sen, G. C. (2009) · BioFactors · doi:10.1002/biof.6 · Cited by 396 · see citing works
Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00527-07 · Cited by 386 · see citing works
Abraham, E. H. (1997) · JAMA · doi:10.1001/jama.1997.03540430043031 · Cited by 377 · see citing works
Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice
Szretter, K. J., Gangappa, S., Lu, X., Smith, C. S., Shieh, W., Zaki, S. R., Sambhara, S. R., Tumpey, T. M., & Katz, J. M. (2006) · Journal of Virology · doi:10.1128/jvi.02336-06 · Cited by 373 · see citing works
Evolutionary divergence and functions of the human interleukin (IL) gene family
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-5-1-30 · Cited by 368 · see citing works
Chemokines in health and disease
Raman, D., Sobolik-Delmaire, T., & Richmond, A. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.005 · Cited by 366 · see citing works
Cytokine storm in acute pancreatitis.
Makhija, R., & Kingsnorth, A. N. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200049 · Cited by 365 · see citing works
Schmitz, N., Kurrer, M. O., Bachmann, M. F., & Köpf, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6441-6448.2005 · Cited by 364 · see citing works
Baskin, C. R., Bielefeldt-Ohmann, H., Tumpey, T. M., Sabourin, P. J., Long, J. P., García-Sastre, A., Tolnay, A.-E., Albrecht, R., Pyles, J. A., Olson, P. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813234106 · Cited by 361 · see citing works
Self-citationPresenting and exploring biological pathways with PathVisio
van Iersel, M., Kelder, T., Pico, A. R., Hanspers, K., Coort, S. L., Conklin, B. R., & Evelo, C. T. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-399 · Cited by 360 · see citing works
Dinarello, C. A., Arend, W. P., Sims, J. E., Smith, D. E., Blumberg, H., O'Neill, L. A. J., Goldbach‐Mansky, R. T., Pizarro, T. T., Hoffman, H. M., Bufler, P., et al. (2010) · Nature Immunology · doi:10.1038/ni1110-973 · Cited by 351 · see citing works
Critical Role of IL-17RA in Immunopathology of Influenza Infection
Crowe, C. R., Chen, K., Pociask, D. A., Alcorn, J. F., Krivich, C., Enelow, R. I., Ross, T. M., Witztum, J. L., & Kolls, J. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900995 · Cited by 347 · see citing works
Meijvis, S., Hardeman, H., Remmelts, H., Heijligenberg, R., Rijkers, G., van Velzen-Blad, H., Voorn, G. P., van de Garde, E. V. D., Endeman, H., Grutters, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60607-7 · Cited by 346 · see citing works
Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome
Brun‐Buisson, C., Richard, J.-C., Mercat, A., Thiébaut, A. C. M., & Brochard, L. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0135oc · Cited by 335 · see citing works
Genetic analysis of complex traits in the emerging Collaborative Cross
Aylor, D. L., Valdar, W., Foulds-Mathes, W., Buus, R. J., Verdugo, R. A., Baric, R. S., Ferris, M. T., Frelinger, J. A., Heise, M., Frieman, M. B., et al. (2011) · Genome Research · doi:10.1101/gr.111310.110 · Cited by 328 · see citing works
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J., Paludan, S. R., Klucher, K. M., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 326 · see citing works
Pugin, J., Ricou, B., Steinberg, K. P., Suter, P. M., & Martin, T. R. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.153.6.8665045 · Cited by 323 · cited 1× · see citing works
“IL-1 is a key cytokine driving proinflammatory activity in bronchoalveolar lavage fluid of patients with lung injury (118).”
BackgroundSelf-citationMockenhaupt, F. P., Cramer, J. P., Hamann, L., Stegemann, M. S., Eckert, J., Oh, N. R., Otchwemah, R. N., Dietz, E., Ehrhardt, S., Schröder, N. W. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506803102 · Cited by 320 · see citing works
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
Kurahashi, K., Kajikawa, O., Sawa, T., Ohara, M., Gropper, M. A., Frank, D. W., Martin, T. R., & Wiener-Kronish, J. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7124 · Cited by 316 · see citing works
Self-citationA20: Central Gatekeeper in Inflammation and Immunity
Coornaert, B., Carpentier, I., & Beyaert, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800032200 · Cited by 310 · see citing works
Zheng, B.-J., Chan, K.-W., Lin, Y.-P., Zhao, G.-Y., Chan, C., Zhang, H.-J., Chen, H.-L., Wong, S. S. Y., Lau, S. K. P., Woo, P. C. Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711942105 · Cited by 302 · see citing works
Possible importance of macrophage-derived mediators in acute malaria
Clark, I. A., Virelizier, J. L., Carswell, E. A., & Wood, P. R. (1981) · Infection and Immunity · doi:10.1128/iai.32.3.1058-1066.1981 · Cited by 294 · see citing works
Respiratory Syncytial Virus Up-regulates TLR4 and Sensitizes Airway Epithelial Cells to Endotoxin
Monick, M. M., Yarovinsky, T. O., Powers, L. S., Butler, N. S., Carter, A. B., Gudmundsson, G., & Hunninghake, G. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308093200 · Cited by 276 · see citing works
Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella Endotoxin
da Silva, A. M. T., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F., & Danner, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282005 · Cited by 276 · see citing works
Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells
Seo, S. H., & Webster, R. G. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1071-1076.2002 · Cited by 275 · see citing works
Imashuku, S. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00117-8 · Cited by 271 · see citing works
How TNF was recognized as a key mechanism of disease
Clark, I. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.04.002 · Cited by 269 · see citing works
Averting inflammation by targeting the cytokine environment
Köpf, M., Bachmann, M. F., & Marsland, B. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2805 · Cited by 256 · see citing works
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 252 · see citing works
Sun, L., Louie, M. C., Vannella, K. M., Wilke, C. A., LeVine, A. M., Moore, B. B., & Shanley, T. P. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2010 · Cited by 251 · see citing works
Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis
Wurfel, M. M., Gordon, A. C., Holden, T. D., Radella, F., Strout, J., Kajikawa, O., Ruzinski, J. T., Rona, G., Black, A. R., Stratton, S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-462oc · Cited by 244 · see citing works
Self-citationInnate immune responses to influenza A H5N1: friend or foe?
Peiris, J. S. M., Cheung, C. Y., Leung, C. Y. H., & Nicholls, J. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.004 · Cited by 232 · see citing works
Willinger, T., Rongvaux, A., Takizawa, H., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Auerbach, W., Eynon, E. E., Stevens, S. G., Manz, M. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019682108 · Cited by 224 · see citing works
Cytokine dysregulation as a mechanism of graft versus host disease
Ferrara, J. L. M. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90139-j · Cited by 222 · see citing works
Cillóniz, C., Shinya, K., Peng, X., Korth, M. J., Proll, S. C., Aicher, L. D., Carter, V. S., Chang, J. H., Kobasa, D., Feldmann, F., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000604 · Cited by 210 · see citing works
Self-citationSimmons, C. P., Popper, S. J., Dolocek, C., Chau, T. N. B., Griffiths, M. J., Dung, N. T. P., Long, T. H., Hoang, D. M., Chau, N. V., Thao, L. T. T., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512162 · Cited by 194 · see citing works
Self-citationFranklin, B. S., Parroche, P., Ataíde, M. A., Lauw, F., Ropert, C., de Oliveira, R. B., Pereira, D., Tada, M. S., Nogueira, P., da Silva, L. H. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809742106 · Cited by 193 · see citing works
Pathophysiologic and Prognostic Role of Cytokines in Dengue Hemorrhagic Fever
Bethell, D. B., Flobbe, K., Phuong, C. X. T., Day, N. P. J., Phuong, P. T., Buurman, W. A., Cardosa, M. J., White, N. J., & Kwiatkowski, D. (1998) · The Journal of Infectious Diseases · doi:10.1086/517807 · Cited by 180 · see citing works
Jahrling, P. B., Hensley, L. E., Martinez, M., LeDuc, J. W., Rubins, K., Relman, D. A., & Huggins, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405954101 · Cited by 170 · see citing works
Human infection by avian influenza A H5N1.
Yuen, K., & Wong, S. S. Y. (2005) · PubMed · Cited by 167 · see citing works
Österlund, P., Pirhonen, J., Ikonen, N., Rönkkö, E., Strengell, M., Mäkelä, S. M., Broman, M., Hamming, O. J., Hartmann, R., Ziegler, T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01619-09 · Cited by 162 · see citing works
Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study
Bate, R., Coticelli, P., Tren, R., & Attaran, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002132 · Cited by 161 · see citing works
The advent of the cytokine storm
Clark, I. A. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100062 · Cited by 160 · see citing works
Host response to influenza virus: protection versus immunopathology
Peiris, M. J. S., Hui, K. P. Y., & Yen, H. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.003 · Cited by 160 · see citing works
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158 · see citing works
The cytokine storm in multiple sclerosis
Link, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400104 · Cited by 155 · see citing works
Srikiatkhachorn, A., Ajariyakhajorn, C., Endy, T. P., Kalayanarooj, S., Libraty, D. H., Green, S., Ennis, F. A., & Rothman, A. L. (2006) · Journal of Virology · doi:10.1128/jvi.01642-06 · Cited by 149 · see citing works
Innate immune modulation by RNA viruses: emerging insights from functional genomics
Katze, M. G., Fornek, J. L., Palermo, R. E., Walters, K., & Korth, M. J. (2008) · Nature reviews. Immunology · doi:10.1038/nri2377 · Cited by 148 · see citing works
Self-citationMichel, O., LeVan, T. D., Stern, D., Dentener, M., Thorn, J., Gnat, D., Beijer, M. L., Cochaux, P., Holt, P. G., Martinez, F. D., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.05.001 · Cited by 147 · see citing works
Mockenhaupt, F. P., Hamann, L., von Gaertner, C., Bedu‐Addo, G., von Kleinsorgen, C., Schumann, R. R., & Bienzle, U. (2006) · The Journal of Infectious Diseases · doi:10.1086/505152 · Cited by 144 · see citing works
Chen, I.-Y., Chang, S. C., Wu, H.-Y., Yu, T.-C., Wei, W.-C., Lin, S., Chien, C.-L., & Chang, M.-F. (2010) · Journal of Virology · doi:10.1128/jvi.02560-09 · Cited by 141 · see citing works
TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide
Tulic, M. K., Hurrelbrink, R. J., Prêle, C. M., Laing, I. A., Upham, J. W., Le Souef, P., Sly, P. D., & Holt, P. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.132 · Cited by 140 · see citing works
Hoang, L. T., Lynn, D. J., Henn, M., Birren, B. W., Lennon, N. J., Le, P. T., Duong, K. T. H., Nguyen, T. T. H., Mai, L. N., Farrar, J. J., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01224-10 · Cited by 137 · see citing works
Self-citationCilloniz, C., Pantin-Jackwood, M. J., Ni, C., Goodman, A. G., Peng, X., Proll, S. C., Carter, V. S., Rosenzweig, E. R., Szretter, K. J., Katz, J. M., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00553-10 · Cited by 136 · see citing works
Self-citation<i>CISH</i> and Susceptibility to Infectious Diseases
Khor, C. C., Vannberg, F. O., Chapman, S. J., Guo, H., Wong, S. H., Walley, A. J., Vukcevic, D., Rautanen, A., Mills, T. C., Chang, K.-C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905606 · Cited by 136 · see citing works
Wurfel, M. M., Park, W. Y., Radella, F., Ruzinski, J., Sandstrom, A., Strout, J., Bumgarner, R. E., & Martin, T. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2570 · Cited by 130 · see citing works
Self-citationRole of CCL5 (RANTES) in Viral Lung Disease
Culley, F. J., Pennycook, A. M. J., Tregoning, J. S., Dodd, J. S., Walzl, G., Wells, T. N., Hussell, T., & Openshaw, P. J. M. (2006) · Journal of Virology · doi:10.1128/jvi.00496-06 · Cited by 126 · see citing works
Marsolais, D., Hahm, B., Walsh, K. B., Edelmann, K. H., McGavern, D., Hatta, Y., Kawaoka, Y., Rosen, H., & Oldstone, M. B. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812689106 · Cited by 122 · see citing works
Lee, S. M. Y., Cheung, C. Y., Nicholls, J. M., Hui, K. P. Y., Leung, C. Y. H., Uiprasertkul, M., Tipoe, G. L., Lau, Y., Poon, L. L. M., Ip, N. Y., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590499 · Cited by 122 · see citing works
Targeting TNF for Treatment of Cancer and Autoimmunity
Sethi, G., Sung, B., Kunnumakkara, A. B., & Aggarwal, B. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_3 · Cited by 117 · see citing works
Perrone, L. A., Szretter, K. J., Katz, J. M., Mizgerd, J. P., & Tumpey, T. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/656365 · Cited by 105 · see citing works
A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection
Humphreys, I. R., Walzl, G., Edwards, L., Rae, A. J., Hill, S., & Hussell, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030351 · Cited by 105 · see citing works
Increased Survival after Gemfibrozil Treatment of Severe Mouse Influenza
Budd, A. C., Alleva, L. M., Alsharifi, M., Koskinen, A. M. L., Smythe, V., Müllbacher, A., Wood, J. T., & Clark, I. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00219-07 · Cited by 101 · see citing works
Friedman, R. M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03055.x · Cited by 95 · see citing works
Lin, K. L., Sweeney, S., Kang, B. D., Ramsburg, E. A., & Gunn, M. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001002 · Cited by 92 · see citing works
Simmons, C. P., Thwaites, G. E., Quyen, N. T. H., Török, M. E., Hoang, D. M., Chau, T. T. H., Phuong, P., Lan, N. T. N., Dung, N. H., Quy, H. T., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.2007 · Cited by 90 · see citing works
Self-citationHost Regulatory Network Response to Infection with Highly Pathogenic H5N1 Avian Influenza Virus
Li, C., Bankhead, A., Eisfeld, A. J., Hatta, Y., Jeng, S., Chang, J. H., Aicher, L. D., Proll, S. C., Ellis-Connell, A. L., Law, G. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05792-11 · Cited by 88 · see citing works
Self-citationPandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques
Safronetz, D., Rockx, B., Feldmann, F., Belisle, S. E., Palermo, R. E., Brining, D., Gardner, D., Proll, S. C., Marzi, A., Tsuda, Y., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01848-10 · Cited by 86 · see citing works
Self-citationDung, N. T. P., Duyen, H. T. L., Thuy, N. T. V., Ngoc, T. V., Châu, N. V. V., Hien, T. T., Rowland‐Jones, S., Dong, T., Farrar, J., Wills, B. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903262 · Cited by 86 · see citing works
Self-citationH5N1 Influenza Virus Pathogenesis in Genetically Diverse Mice Is Mediated at the Level of Viral Load
Boon, A. C. M., Finkelstein, D., Zheng, M., Liao, G., Allard, J. D., Klumpp, K., Webster, R. G., Peltz, G., & Webby, R. J. (2011) · mBio · doi:10.1128/mbio.00171-11 · Cited by 85 · see citing works
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Bassaganya-Riera, J., Song, R., Roberts, P. C., & Hontecillas, R. (2010) · Viral Immunology · doi:10.1089/vim.2010.0016 · Cited by 83 · see citing works
Long, H. T., Hibberd, M. L., Hien, T. T., Dung, N. M., Ngoc, T. V., Farrar, J., Wills, B. A., & Simmons, C. P. (2009) · The Journal of Infectious Diseases · doi:10.1086/596507 · Cited by 83 · see citing works
Self-citationPankhaniya, R. R., Tamura, M., Allmond, L. R., Moriyama, K., Ajayi, T., Wiener-Kronish, J. P., & Sawa, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145588.79063.07 · Cited by 81 · see citing works
Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited
Barry, S., Johnson, M., & Janossy, G. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702562 · Cited by 81 · see citing works
Mini-review series: focus on chemokines
Comerford, I., & McColl, S. R. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.164 · Cited by 81 · see citing works
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia
Dessing, M. C., van der Sluijs, K. F., Florquin, S., & van der Poll, T. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.001 · Cited by 78 · see citing works
Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
Carey, M. A., Bradbury, J. A., Rebolloso, Y. D., Graves, J. P., Zeldin, D. C., & Germolec, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011610 · Cited by 77 · see citing works
Belisle, S. E., Tisoncik, J. R., Korth, M. J., Carter, V. S., Proll, S. C., Swayne, D. E., Pantin-Jackwood, M., Tumpey, T. M., & Katze, M. G. (2010) · Journal of Virology · doi:10.1128/jvi.01310-10 · Cited by 70 · see citing works
Self-citationViasus, D., Paño‐Pardo, J. R., Cordero, E., Campins, A. A., López‐Medrano, F., Villoslada, A., Fariñas, M. C., Moreno, A., Rodríguez‐Baño, J., Oteo, J. A., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.01.014 · Cited by 69 · see citing works
Tsai, S. K., Huang, C., Huang, S. S., Hung, L., & Hong, C. Y. (1999) · Pharmacology · doi:10.1159/000028324 · Cited by 67 · see citing works
Ma, W., Belisle, S. E., Mosier, D. A., Li, X., Stigger-Rosser, E., Liu, Q., Qiao, C., Elder, J., Webby, R. J., Katze, M. G., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05705-11 · Cited by 67 · see citing works
Self-citationExperimental Infection of Pigs with the Human 1918 Pandemic Influenza Virus
Weingartl, H. M., Albrecht, R. A., Lager, K. M., Babiuk, S., Marszal, P., Neufeld, J., Embury‐Hyatt, C., Lekcharoensuk, P., Tumpey, T. M., García‐Sastre, A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02399-08 · Cited by 67 · see citing works
Alberts, R., Srivastava, B., Wu, H., Viegas, N., Geffers, R., Klawonn, F., Novoselova, N., do Valle, T. Z., Panthier, J., & Schughart, K. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.01.008 · Cited by 58 · see citing works
Becerra, A., Warke, R. V., Martin, K. J., Xhaja, K., de Bosch, N., Rothman, A. L., & Bosch, I. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21538 · Cited by 56 · see citing works
Fowler, A. A., Fisher, B. J., Centor, R. M., & Carchman, R. A. (1984) · PubMed Central · Cited by 54 · see citing works
Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase
Houde, M., & Arora, D. J. S. (1990) · Cellular Immunology · doi:10.1016/0008-8749(90)90190-3 · Cited by 54 · see citing works
Structured regulation of inflammation during respiratory viral infection
Hussell, T., & Goulding, J. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70067-0 · Cited by 53 · see citing works
Danesh, A., Cameron, C. M., León, A. J., Ran, L., Xu, L., Fang, Y., Kelvin, A. A., Rowe, T., Chen, H., Guan, Y., et al. (2011) · Virology · doi:10.1016/j.virol.2010.10.002 · Cited by 51 · see citing works
Insights into Inflammation and Influenza
Simmons, C. P., & Farrar, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmcibr0805865 · Cited by 49 · see citing works
Self-citationZornetzer, G. A., Frieman, M. B., Rosenzweig, E., Korth, M. J., Page, C., Baric, R. S., & Katze, M. G. (2010) · Journal of Virology · doi:10.1128/jvi.01130-10 · Cited by 48 · see citing works
Self-citationChemokines as targets for therapy
Garin, A., & Proudfoot, A. E. I. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.021 · Cited by 45 · see citing works
Humphreys, I. R., Edwards, L., Walzl, G., Rae, A. J., Dougan, G., Hill, S., & Hussell, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6125 · Cited by 45 · see citing works
Lee, S. M., Chan, R. W., Gardy, J. L., Lo, C.-K., Sihoe, A. D., Kang, S. S., Cheung, T. K., Guan, Y., Chan, M. C., Hancock, R. E., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-147 · Cited by 43 · see citing works
McDermott, J., Shankaran, H., Eisfeld, A. J., Belisle, S. E., Neumann, G., Li, C., McWeeney, S. K., Sabourin, C. L. K., Kawaoka, Y., Katze, M. G., et al. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-190 · Cited by 41 · see citing works
Self-citation[Influenza-associated encephalopathy--pathophysiology and disease mechanisms].
Yokota, S. (2003) · PubMed · Cited by 40 · see citing works
TGF-β prevents eosinophilic lung disease but impairs pathogen clearance
Williams, A. E., Humphreys, I. R., Cornere, M. M., Edwards, L., Rae, A. J., & Hussell, T. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2004.11.012 · Cited by 36 · see citing works
Arnold, R., Neumann, M., & König, W. (2007) · Immunology · doi:10.1111/j.1365-2567.2006.02539.x · Cited by 29 · see citing works
Genetic Insights into Sepsis: What have we Learned and How will it Help?
Wurfel, M. M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784980554 · Cited by 29 · see citing works
Housseau, F., Moorthy, A., Langer, D., Robbins, P. F., Gonzales, M. I., & Topalian, S. L. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9 · Cited by 20 · see citing works
Influenza A Virus Infects Macrophages and Stimulates Release of Tumor Necrosis Factor-Alpha
Hinder, F., Schmidt, A., Gong, J.-H., Bender, A., Sprenger, H., Nain, M., & Gemsa, D. (2008) · Pathobiology · doi:10.1159/000163651 · Cited by 20 · cited 1× · see citing works
“It is highly expressed across infection models, including primary human respiratory epithelial cells (24, 125) and human monocyte-derived macrophages (26, 59, 62), compared with during seasonal H1N1 influenza virus and swine-origin H1N1 influenza virus (SOIV) infection (111).”
Result
Flagged first, then by citations
1 of the 162 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cytokines in Inflammatory Disease
Kany, S., Vollrath, J. T., & Relja, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236008 · Cited by 2,027 · see citing works
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734 · see citing works
Shimabukuro‐Vornhagen, A., Gödel, P., Subklewe, M. S., Stemmler, H., Schlößer, H., Schlaak, M. S., Kochanek, M., Böll, B., & von Bergwelt‐Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,673 · see citing works
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654 · see citing works
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Świrski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,340 · see citing works
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295 · see citing works
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288 · see citing works
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G. D. H., Voors, A. A., Osterhaus, A. D. M. E., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,119 · see citing works
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094 · see citing works
Innate immunity to influenza virus infection
Iwasaki, A., & Pillai, P. S. (2014) · Nature reviews. Immunology · doi:10.1038/nri3665 · Cited by 1,064 · see citing works
Chua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Völker, M. T., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0602-4 · Cited by 1,035 · see citing works
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 966 · see citing works
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Rosshart, S. P., Vassallo, B. G., Angeletti, D., Hutchinson, D. S., Morgan, A. P., Takeda, K., Hickman, H. D., McCulloch, J. A., Badger, J. H., Ajami, N. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.016 · Cited by 862 · see citing works
COVID-19: what has been learned and to be learned about the novel coronavirus disease
Ye, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 836 · see citing works
Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality
Ogen, Y. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138605 · Cited by 817 · see citing works
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Kaneko, N., Kuo, H.-H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., Piechocka-Trocha, A., Lefteri, K., Osborn, M., Bals, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.025 · Cited by 734 · see citing works
Wang, J., Jiang, M., Chen, X., & Montaner, L. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3covr0520-272r · Cited by 730 · see citing works
The cytokine storm of severe influenza and development of immunomodulatory therapy
Liu, Q., Zhou, Y., & Yang, Z. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 714 · see citing works
Akhmerov, A., & Marbán, E. (2020) · Circulation Research · doi:10.1161/circresaha.120.317055 · Cited by 694 · see citing works
Nadim, M. K., Forni, L. G., Mehta, R. L., Connor, M. J., Jr., Liu, K. D., Ostermann, M., Rimmele, T. R., Zarbock, A., Bell, S., Bihorac, A., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00356-5 · Cited by 688 · see citing works
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 599 · see citing works
Nieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Fernández‐Delgado, R., Castaño-Rodríguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 560 · see citing works
Cytokine storm induced by SARS-CoV-2
Song, P., Li, W., Xie, J., Hou, Y., & You, C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.017 · Cited by 540 · see citing works
Zoran, M. A., Savastru, R., Savastru, D. M., & Tautan, M. N. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139825 · Cited by 493 · see citing works
Invited review: Inflammation during the transition to lactation: New adventures with an old flame
Bradford, B. J., Yuan, K., Farney, J. K., Mamedova, L. K., & Carpenter, A. J. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-9683 · Cited by 480 · see citing works
PathVisio 3: An Extendable Pathway Analysis Toolbox
Kutmon, M., van Iersel, M., Bohler, A., Kelder, T., Nunes, N. M., Pico, A. R., & Evelo, C. T. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004085 · Cited by 465 · see citing works
COVID-19 cytokine storm: the anger of inflammation
Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., & Nabipour, I. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155151 · Cited by 461 · see citing works
COVID-19 infection and rheumatoid arthritis: Faraway, so close
Favalli, E. G., Ingegnoli, F., De Lucia, O., Cincinelli, G., Cimaz, R., & Caporali, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102523 · Cited by 454 · see citing works
Deng, Q., Hu, B., Zhang, Y., Wang, H., Zhou, X., Hu, W., Cheng, Y., Yan, J., Ping, H., & Zhou, Q. T. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.087 · Cited by 451 · see citing works
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 445 · see citing works
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Nile, S. H., Nile, A. S., Qiu, J., Li, L., Jia, X., & Kai, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.002 · Cited by 440 · see citing works
Baral, P., Umans, B. D., Li, L., Wallrapp, A., Bist, M., Kirschbaum, T., Wei, Y., Zhou, Y., Kuchroo, V. K., Burkett, P. R., et al. (2018) · Nature Medicine · doi:10.1038/nm.4501 · Cited by 430 · see citing works
Targeting the NLRP3 Inflammasome in Severe COVID-19
Freeman, T. L., & Swartz, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01518 · Cited by 406 · see citing works
Kindrachuk, J., Ork, B. L., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03659-14 · Cited by 402 · see citing works
COVID-19: A Multidisciplinary Review
Chams, N., Chams, S., Badran, R., Shams, A., Araji, A., Raad, M., Mukhopadhyay, S., Stroberg, E., Duval, E. J., Barton, L. M., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00383 · Cited by 401 · see citing works
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Oladunni, F. S., Park, J.-G., Pino, P., Gonzalez, O., Akhter, A., Allué-Guardia, A., Olmo-Fontánez, A. M., Gautam, S., Garcia-Vilanova, A., Ye, C.-J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19891-7 · Cited by 394 · see citing works
Redox Biology of Respiratory Viral Infections
Khomich, O. A., Kochetkov, S. N., Bartosch, B., & Ivanov, A. V. (2018) · Viruses · doi:10.3390/v10080392 · Cited by 381 · see citing works
Opportunities and challenges in the diagnostic utility of dermal interstitial fluid
Friedel, M., Thompson, I. A. P., Kasting, G. B., Polsky, R., Cunningham, D. D., Soh, H. T., & Heikenfeld, J. C. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00998-9 · Cited by 381 · see citing works
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara, A. F., Mitrev, Z. K., Rosalia, R. A., & Assas, M. B. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 368 · see citing works
d’Enfert, C., Kaune, A.-K., Alaban, L. R., Chakraborty, S., Cole, N. L., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 351 · see citing works
Liao, H., Ye, J., Gao, L., & Liu, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110917 · Cited by 341 · see citing works
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 340 · see citing works
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J., & Pickkers, P. (2020) · JAMA · doi:10.1001/jama.2020.17052 · Cited by 333 · see citing works
Ryan, P. M., & Caplice, N. M. (2020) · Obesity · doi:10.1002/oby.22843 · Cited by 323 · see citing works
Targeting the “Cytokine Storm” for Therapeutic Benefit
D’Elia, R. V., Harrison, K., Oyston, P. C. F., Lukaszewski, R. A., & Clark, G. C. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00636-12 · Cited by 322 · see citing works
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Zhang, Y., Geng, X., Tan, Y., Li, Q., Xu, C., Xu, J., Hao, L., Zeng, Z., Luo, X., Liu, F., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110195 · Cited by 319 · see citing works
Starkey, J., Kobayashi, N., Numaguchi, Y., & Moritani, T. (2017) · Radiographics · doi:10.1148/rg.2017160085 · Cited by 316 · see citing works
Cytokine Storm—Definition, Causes, and Implications
Jarczak, D., & Nierhaus, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911740 · Cited by 317 · see citing works
Girija, A. S. S., Shankar, E. M., & Larsson, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01206 · Cited by 308 · see citing works
Perico, L., Benigni, A., & Remuzzi, G. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000507305 · Cited by 305 · see citing works
A materials-science perspective on tackling COVID-19
Tang, Z., Kong, N., Zhang, X., Liu, Y., Hu, P., Mou, S., Liljeström, P., Shi, J., Tan, W., Kim, J. S., et al. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00247-y · Cited by 302 · see citing works
Dheda, K. U. J., Perumal, T., Moultrie, H., Perumal, R., Esmail, A., Scott, A., Udwadia, Z., Chang, K. C., Peter, J., Pooran, A., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00092-3 · Cited by 301 · see citing works
Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 297 · see citing works
Self-citationNew fronts emerge in the influenza cytokine storm
Guo, X.-Z. J., & Thomas, P. G. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0636-y · Cited by 295 · see citing works
Tie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283 · see citing works
Host-Directed Antiviral Therapy
Kumar, N., Sharma, S., Kumar, R., Tripathi, B. N., Barua, S., Ly, H., & Rouse, B. T. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00168-19 · Cited by 281 · see citing works
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Wang, Z., & Han, W. (2018) · Biomarker Research · doi:10.1186/s40364-018-0116-0 · Cited by 277 · see citing works
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 276 · see citing works
Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals
Sang, D., Lin, K., Yang, Y., Ran, G., Li, B., Chen, C., Li, Q., Ma, Y., Lu, L., Cui, X., et al. (2023) · Cell · doi:10.1016/j.cell.2023.10.025 · Cited by 278 · see citing works
Cytokines and Chemokines in Periodontitis
Ramadan, D. E., Hariyani, N., Indrawati, R., Ridwаn, R. D., & Diyatri, I. (2020) · European Journal of Dentistry · doi:10.1055/s-0040-1712718 · Cited by 275 · see citing works
Mazini, L., Ezzoubi, M., & Malka, G. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02006-w · Cited by 269 · see citing works
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Copaescu, A. M., Smibert, O. C., Gibson, A., Phillips, E. J., & Trubiano, J. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.001 · Cited by 258 · see citing works
McAuley, J., Tate, M. D., Mackenzie-Kludas, C., Pinar, A. A., Zeng, W., Stutz, A., Latz, E., Brown, L. E., & Mansell, A. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003392 · Cited by 247 · see citing works
Ritchie, S. C., Würtz, P., Nath, A. P., Abraham, G., Havulinna, A. S., Fearnley, L. G., Sarin, A., Kangas, A. J., Soininen, P., Aalto, K., et al. (2015) · Cell Systems · doi:10.1016/j.cels.2015.09.007 · Cited by 246 · see citing works
Zoran, M. A., Savastru, R., Savastru, D. M., & Tautan, M. N. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140005 · Cited by 246 · see citing works
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Farsalinos, K. E., NIAURA, R. S., Houezec, J. L., Barbouni, A., Tsatsakis, A. M., Kouretas, D., Vantarakis, A., & Poulas, K. A. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.04.012 · Cited by 246 · see citing works
Nugraha, R. V., Ridwansyah, H., Ghozali, M., Khairani, A. F., & Atik, N. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2560645 · Cited by 242 · see citing works
TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation
Pietro, A. D., Kajaste‐Rudnitski, A., Oteiza, A., Nicora, L., Towers, G. J., Mechti, N., & Vicenzi, E. (2013) · Journal of Virology · doi:10.1128/jvi.02548-12 · Cited by 241 · see citing works
Chen, L., Qin, H., Zhao, R., Zhao, X., Lin, L., Chen, Y., Lin, Y., Li, Y., Qin, Y., Li, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2816 · Cited by 240 · see citing works
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
Perricone, C., Bartoloni, E., Bursi, R., Cafaro, G., Guidelli, G. M., Shoenfeld, Y., & Gerli, R. (2020) · Immunologic Research · doi:10.1007/s12026-020-09145-5 · Cited by 238 · see citing works
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
Luo, J., Rizvi, H. A., Egger, J. V., Preeshagul, I. R., Wolchok, J. D., & Hellmann, M. D. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0596 · Cited by 234 · see citing works
The Mechanism behind Influenza Virus Cytokine Storm
Gu, Y., Zuo, X., Zhang, S., Ouyang, Z., Jiang, S., Wang, F., & Wang, G. (2021) · Viruses · doi:10.3390/v13071362 · Cited by 233 · see citing works
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works
Is the kidney a target of SARS-CoV-2?
Martínez-Rojas, M. A., Vega‐Vega, O., & Bobadilla, N. A. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2020 · Cited by 231 · see citing works
A Role for Neutrophils in Viral Respiratory Disease
Camp, J. V., & Jonsson, C. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00550 · Cited by 222 · see citing works
Sphingosine-1-Phosphate and Its Receptors: Structure, Signaling, and Influence
Rosen, H., Stevens, R. C., Hanson, M. A., Roberts, E., & Oldstone, M. B. A. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062411-130916 · Cited by 221 · see citing works
Gene expression variability across cells and species shapes innate immunity
Hagai, T., Chen, X., Miragaia, R. J., Rostom, R., Gomes, T., Kunowska, N., Henriksson, J., Park, J.-E., Proserpio, V., Donati, G., et al. (2018) · Nature · doi:10.1038/s41586-018-0657-2 · Cited by 220 · see citing works
Santoso, A., Pranata, R., Wibowo, A., Farabi, M. J. A., Huang, I., & Antariksa, B. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.04.052 · Cited by 217 · see citing works
Yang, R., Liu, H., Bai, C., Wang, Y., Zhang, X., Guo, R., Wu, S., Wang, J., Leung, E. L., Chang, H., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104820 · Cited by 217 · see citing works
Acute Inflammation and Metabolism
Varela, M., Mogildea, M., Moreno, I., & Lopes, A. L. N. (2018) · Inflammation · doi:10.1007/s10753-018-0739-1 · Cited by 216 · see citing works
Tate, M. D., Ong, J. D. H., Dowling, J. K., McAuley, J., Robertson, A. A. B., Latz, E., Drummond, G. R., Cooper, M. A., Hertzog, P. J., & Mansell, A. S. (2016) · Scientific Reports · doi:10.1038/srep27912 · Cited by 215 · see citing works
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Zhang, S., Li, L., Shen, A., Chen, Y., & Qi, Z. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00917-3 · Cited by 213 · see citing works
Hotchkiss, R. S., Colston, E., Yende, S. P., Crouser, E. D., Martin, G. S., Albertson, T. E., Bartz, R. R., Brakenridge, S. C., Delano, M. J., Park, P. K., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05704-z · Cited by 212 · see citing works
Hart, B. J., Dyall, J., Postnikova, E. N., Zhou, H., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Frieman, M. B., Holbrook, M. R., Jahrling, P. B., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.061911-0 · Cited by 211 · see citing works
Qiao, Q., Liu, X., Yang, T., Cui, K., Kong, L., Yang, C., & Zhang, Z. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.023 · Cited by 208 · see citing works
Dhar, S. K., Vishnupriyan, K., Damodar, S., Gujar, S. A., & Das, M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06155 · Cited by 207 · see citing works
Hennon, T., Penque, M. D., Abdul‐Aziz, R., Alibrahim, O. S., McGreevy, M. B., Prout, A. J., Schaefer, B. A., Ambrusko, S. J., Pastore, J. V., Turkovich, S. J., et al. (2020) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2020.101232 · Cited by 207 · see citing works
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Kircheis, R., Haasbach, E., Lueftenegger, D., Heyken, W. T., Ocker, M., & Planz, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.598444 · Cited by 205 · see citing works
Amelioration of sepsis by TIE2 activation–induced vascular protection
Han, S., Lee, S.-J., Kim, K. E., Lee, H. S., Oh, N., Park, I., Ko, E., Oh, S. J., Lee, Y.-S., Kim, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9260 · Cited by 203 · see citing works
Dyall, J., Gross, R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Hensley, L. E., Frieman, M. B., & Jahrling, P. B. (2017) · Drugs · doi:10.1007/s40265-017-0830-1 · Cited by 202 · see citing works
The Foreign Body Response Demystified
Chandorkar, Y., K, R., & Basu, B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00252 · Cited by 201 · see citing works
Genetics Insight for COVID-19 Susceptibility and Severity: A Review
Fricke-Galindo, I., & Falfán‐Valencia, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622176 · Cited by 200 · see citing works
Guo, C., Li, B., Ma, H., Wang, X., Cai, P., Yu, Q., Zhu, L., Jin, L., Jiang, C., Fang, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17834-w · Cited by 199 · see citing works
Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Gao, Y.-M., Xu, G., Wang, B., & Liu, B. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13144 · Cited by 198 · see citing works
A review of cytokine-based pathophysiology of Long COVID symptoms
Low, R. N., Low, R. J., & Akrami, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1011936 · Cited by 196 · see citing works
Crucian, B. E., Zwart, S. R., Mehta, S., Uchakin, P., Quiriarte, H. D., Pierson, D., Sams, C. F., & Smith, S. M. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0129 · Cited by 195 · see citing works
Li, B., Jiang, J., Assaraf, Y. G., Xiao, H., Chen, Z., & Huang, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100720 · Cited by 189 · see citing works
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
Pyrillou, K., Burzynski, L. C., & Clarke, M. C. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613170 · Cited by 188 · see citing works
Animal models for influenza virus pathogenesis, transmission, and immunology
Thangavel, R. R., & Bouvier, N. M. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.023 · Cited by 185 · see citing works
IL-13 is a driver of COVID-19 severity
Donlan, A. N., Sutherland, T. E., Marie, C. S., Preißner, S., Bradley, B. T., Carpenter, R. M., Sturek, J. M., Ma, J. Z., Moreau, G. B., Donowitz, J. R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150107 · Cited by 182 · see citing works
- Authors
- Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G.
- Affiliations
- Department of Microbiology, University of Washington, Seattle, Washington, USA
- University of Washington (US)
- Oxford University Clinical Research Unit (VN)
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2012-03
- Volume
- 76
- Issue
- 1
- Pages
- 16-32
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- PMC
- PMC3294426
- OpenAlex
- W2129239355
- Semantic Scholar
- 435bd4bfc43c8e55b14aac55445390f0f726da0a
- Cited by
- 1,940
- References
- 162
- Citations by year
- 2026: 41 · 2025: 75 · 2024: 110 · 2023: 159 · 2022: 245 · 2021: 427 · 2020: 453 · 2019: 66 · 2018: 90 · 2017: 65 · 2016: 66 · 2015: 43 · 2014: 54 · 2013: 35 · 2012: 10
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Microbiology and Molecular Biology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (HHSN272200800060C)
- National Institute on Drug Abuse (P30DA015625)
- National Institute of Allergy and Infectious Diseases (U54AI081680, P01AI058113, HHSN272200800060C)
- National Center for Research Resources (P51‐RR00166, R24RR016354, P51RR000166)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- cytokine storm, inflammatory cytokines, viral infection, H5N1 avian influenza, immunomodulatory therapy
- MeSH terms
- Animals, Communicable Diseases, Humans, Signal Transduction, Cytokines, Influenza A Virus, H5N1 Subtype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review